Here are the DEF 14A proxy statements from Medpace Holdings, Inc. (MEDP) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow MEDP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MEDP filings page.
Medpace Holdings, Inc. is asking stockholders to vote at its 2026 virtual annual meeting on director elections, auditor ratification, executive pay advisory votes and several governance changes. The meeting will be held online on May 15, 2026 via www.virtualshareholdermeeting.com/MEDP2026.
Stockholders of record on March 19, 2026, when 28,558,039 common shares were outstanding, may vote. The Board recommends voting for all five director nominees, for ratifying Deloitte & Touche LLP as auditor, for the Say‑on‑Pay resolution, for holding Say‑on‑Pay annually, for removing supermajority voting and for allowing stockholders to call special meetings, and against a similar overlapping stockholder proposal.
The proxy also reviews 2025 performance, including revenue of $2,530.2 million, GAAP net income of $451.1 million, diluted EPS of $15.28 and EBITDA of $557.7 million, all up from 2024, and explains how these results influenced executive compensation decisions.